Cambridge, MA · Founded 2018 · Privately Held (backing)
Operator of a biotechnology company intended to develop breakthrough glycol-therapeutics for patients. Aviceda Therapeutics is based in Cambridge, MA and was founded in 2018. It was valued at $347 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $276 million across 3 recorded rounds; the latest was a $75 million later-stage round in Nov 2024.
PMV mark · valuation
$346.5M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$276.3M
Last round
Later Stage VC
Nov 2024
Team — not yet on record
No current team members for Aviceda Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aviceda Therapeutics with a free account
·The complete investor list: 13 names
·Watch Aviceda Therapeutics: the Monday email on marks, rounds and moves
